Ahlam Al-buhairan

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study

Jeroen Eikenboom, Lysiane Hilbert, Anne‐Sophie Ribba et al. · Journal of Thrombosis and Haemostasis · 2009 · 61 citations

Life Sciences, Genetics, Molecular Genetics +13

Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents

Majed M. Masadeh, Karem H. Alzoubi, Sayer Al‐Azzam et al. · Pathogens · 2016 · 38 citations · Full text

Medicine, Microbiology, Pharmacology +17

Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort

Adel Abuzenadah, Ashley Cartwright, Nawal S. Alshammari et al. · Thrombosis and Haemostasis · 2013 · 14 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin

Majed M. Masadeh, Karem H. Alzoubi, Sayer Al‐Azzam et al. · Clinical Pharmacology Advances and Applications · 2017 · 10 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17